<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">347923</id>
  <title nil="true"/>
  <common-name>2-(4-chlorophenoxy)-n-[4-[1-(4-chlorophenoxy)ethyl]-6-(2-phenylethylamino)-1,3,5-triazin-2-yl]propanamide</common-name>
  <description>2-(4-chlorophenoxy)-n-[4-[1-(4-chlorophenoxy)ethyl]-6-(2-phenylethylamino)-1,3,5-triazin-2-yl]propanamide is a chemical compound with the formula C28H27Cl2N5O3. With an average molecular weight of 552.40 g/mol, 2-(4-chlorophenoxy)-n-[4-[1-(4-chlorophenoxy)ethyl]-6-(2-phenylethylamino)-1,3,5-triazin-2-yl]propanamide is a heavy molecule.</description>
  <cas>53878-54-9</cas>
  <pubchem-id>3041272</pubchem-id>
  <chemical-formula>C28H27Cl2N5O3</chemical-formula>
  <weight>552.4</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T11:46:45Z</created-at>
  <updated-at type="dateTime">2026-08-31T11:46:45Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC(C1=NC(=NC(=N1)NC(=O)C(C)OC2=CC=C(C=C2)Cl)NCCC3=CC=CC=C3)OC4=CC=C(C=C4)Cl</moldb-smiles>
  <moldb-formula>C28H27Cl2N5O3</moldb-formula>
  <moldb-inchi>InChI=1S/C28H27Cl2N5O3/c1-18(37-23-12-8-21(29)9-13-23)25-32-27(31-17-16-20-6-4-3-5-7-20)35-28(33-25)34-26(36)19(2)38-24-14-10-22(30)11-15-24/h3-15,18-19H,16-17H2,1-2H3,(H2,31,32,33,34,35,36)</moldb-inchi>
  <moldb-inchikey>XDCGBXOXXUJIAX-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">551.1490951</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>7</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM343816</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-(4-chlorophenoxy)-n-[4-[1-(4-chlorophenoxy)ethyl]-6-(2-phenylethylamino)-1,3,5-triazin-2-yl]propanamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Benzenoids</superklass>
  <klass>Phenol ethers</klass>
  <subklass nil="true"/>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0298259</sync-id>
  <structure-inchikey>XDCGBXOXXUJIAX-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>40000000100000040000800000000004000000000000000000000080000000000000001000000000200000000000002004000000000000000000200000000000000000000000400400000000800000040020009000000100000208001000000000000000010480000000000000000000000000800000000000800000000000000000040040220000800000000000008080000000800100000000001000000400000000000000000000000000080000000080001000000000000000001000000000000000000200000000000000000000000010000000000000000220000000000000008000000001002040000000000400000000004000000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAmAAAAKQAAAIABBgBgAAAAAQMGAGAAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:46:28Z</structure-indexed-at>
</compound>
